Sales rise 170.51% to Rs 4.22 crore
Net Loss of Suven Life Sciences reported to Rs 20.80 crore in the quarter ended March 2022 as against net loss of Rs 21.61 crore during the previous quarter ended March 2021. Sales rose 170.51% to Rs 4.22 crore in the quarter ended March 2022 as against Rs 1.56 crore during the previous quarter ended March 2021.For the full year,net loss reported to Rs 122.00 crore in the year ended March 2022 as against net loss of Rs 72.15 crore during the previous year ended March 2021. Sales declined 12.17% to Rs 11.84 crore in the year ended March 2022 as against Rs 13.48 crore during the previous year ended March 2021.
ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales4.221.56 171 11.8413.48 -12 OPM %-467.30-1383.33 --1033.70-593.92 - PBDT-19.70-20.50 4 -117.60-73.13 -61 PBT-20.80-21.57 4 -122.00-77.47 -57 NP-20.80-21.61 4 -122.00-72.15 -69
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
